GLRX2/3 and TXN are overexpressed in MM molecular subtypes with adverse prognosis (namely PR, MS, HY), whereas PRDX6 and SOD1 expression are associated with a shorter overall survival [81,128]. Here, SOD1 is linked to Miyoshi myopathy.